Dual Checkpoint Blockade of CTLA-4 and PD-1 Overcomes Low-Tumour Mutational Burden Resistance.
APA
Zheng M (2026). Dual Checkpoint Blockade of CTLA-4 and PD-1 Overcomes Low-Tumour Mutational Burden Resistance.. Clinical oncology (Royal College of Radiologists (Great Britain)), 52, 104061. https://doi.org/10.1016/j.clon.2026.104061
MLA
Zheng M. "Dual Checkpoint Blockade of CTLA-4 and PD-1 Overcomes Low-Tumour Mutational Burden Resistance.." Clinical oncology (Royal College of Radiologists (Great Britain)), vol. 52, 2026, pp. 104061.
PMID
41687139
같은 제1저자의 인용 많은 논문 (5)
- Ruhe Sanjie Tablet ameliorates depression-associated mammary gland hyperplasia by modulating estrogen receptor signaling and CDK2.
- Extensive Isolated Intracranial Recurrence of Primary Mediastinal B-Cell Lymphoma on FDG PET Imaging.
- Single-Domain Antibody Probe with Low Renal Uptake for Claudin 18.2-Targeted PET Imaging of Gastric Cancer: Preclinical and Pilot Clinical Evaluations.
- UCH-L1 down-regulates HER2 expression and increases lapatinib sensitivity by interacting with HSP90 in HER2-positive breast cancer.
- CD38-Targeted Molecular Imaging Probes for Multiple Myeloma: Advances, Challenges, and Opportunities.